Baxter International Inc
NYSE:BAX
Baxter International Inc
Revenue
Baxter International Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Baxter International Inc
NYSE:BAX
|
Revenue
$14.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Baxter International Inc
Revenue Breakdown
Breakdown by Geography
Baxter International Inc
Total Revenue:
14.8B
USD
|
Non-Us:
7.8B
USD
|
Americas:
7B
USD
|
Rest Of World:
4.5B
USD
|
Emerging Markets:
3.3B
USD
|
Breakdown by Segments
Baxter International Inc
See Also
What is Baxter International Inc's Revenue?
Revenue
14.8B
USD
Based on the financial report for Dec 31, 2023, Baxter International Inc's Revenue amounts to 14.8B USD.
What is Baxter International Inc's Revenue growth rate?
Revenue CAGR 10Y
0%
Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Baxter International Inc have been 8% over the past three years , 6% over the past five years .